Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Rural and urban disparities in the evolution of sentinel lymph node utilization in breast cancer.

Arrington AK, Kruper L, Vito C, Yim J, Kim J, Chen SL.

Am J Surg. 2013 Nov;206(5):674-81. doi: 10.1016/j.amjsurg.2013.07.007. Epub 2013 Sep 12.

PMID:
24035212
2.

Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.

Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD.

JAMA Surg. 2014 Aug;149(8):788-96. doi: 10.1001/jamasurg.2014.23.

PMID:
25073831
3.

Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.

Rescigno J, Zampell JC, Axelrod D.

Ann Surg Oncol. 2009 Mar;16(3):687-96. doi: 10.1245/s10434-008-0195-5. Epub 2008 Dec 20.

PMID:
19101768
4.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
5.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
6.

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.

Breast Cancer. 2005;12(3):203-10.

7.

Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma.

Shah DR, Yang AD, Maverakis E, Martinez SR.

J Surg Res. 2013 Oct;184(2):1157-60. doi: 10.1016/j.jss.2013.04.091. Epub 2013 Jun 6.

PMID:
23768765
8.

Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.

Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB.

J Surg Oncol. 2006 Feb 1;93(2):129-32.

PMID:
16425295
9.

Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky.

Conn CA, McMasters KM, Edwards MJ, Martin RC.

Breast J. 2005 Jul-Aug;11(4):231-5.

PMID:
15982387
10.

Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy.

Shah DR, Canter RJ, Khatri VP, Bold RJ, Yang AD, Martinez SR.

Ann Surg Oncol. 2013 Jan;20(1):24-30. doi: 10.1245/s10434-012-2539-4. Epub 2012 Sep 28.

11.

A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.

Kootstra JJ, Hoekstra-Weebers JE, Rietman JS, de Vries J, Baas PC, Geertzen JH, Hoekstra HJ.

Ann Surg Oncol. 2010 Sep;17(9):2384-94. doi: 10.1245/s10434-010-0981-8. Epub 2010 Mar 11.

12.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
13.

Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.

Tan LG, Tan YY, Heng D, Chan MY.

Singapore Med J. 2005 Dec;46(12):693-7.

14.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
15.

Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?

Sanuki N, Takeda A, Amemiya A, Ofuchi T, Ono M, Ogata H, Yamagami R, Hatayama J, Eriguchi T, Kunieda E.

Clin Breast Cancer. 2013 Feb;13(1):69-76. doi: 10.1016/j.clbc.2012.09.005. Epub 2012 Oct 11.

PMID:
23062706
16.

Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.

Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ.

Ann Surg Oncol. 2006 Nov;13(11):1450-6. Epub 2006 Sep 29.

PMID:
17009150
17.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

PMID:
19364968
18.

Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.

Rosing DK, Dauphine CE, Vargas MP, Gonzalez K, Burla M, Kaufmann P, Vargas HI.

Am Surg. 2006 Oct;72(10):939-42.

PMID:
17058740
19.

Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?

Murthy V, Chamberlain RS.

Clin Breast Cancer. 2013 Jun;13(3):180-7. doi: 10.1016/j.clbc.2012.12.001. Epub 2013 Jan 26.

PMID:
23357305
20.

Surgical treatment of early breast cancer in day surgery.

Marrazzo A, Taormina P, David M, Riili I, Lo Gerfo D, Casà L, Noto A, Mercadante S.

Chir Ital. 2007 Sep-Oct;59(5):687-91.

PMID:
18019641

Supplemental Content

Support Center